HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glucagon-like peptide-1 (9-36)

Also Known As:

GLP-1(9-36)

Networked: 8 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Peptide Fragments: 373
    - glucagon-like peptide-1 (9-36): 8
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gastrointestinal Hormones: 573
    - Proglucagon: 128
      - Glucagon-Like Peptides: 424
        Glucagon-Like Peptide 1: 6089
        glucagon-like peptide-1 (9-36): 8

Experts

1.	Marx, Nikolaus: 2 articles (01/2020 - 01/2013)
2.	Cheng, Liusiyuan: 1 article (11/2020)
3.	Huang, Jing: 1 article (11/2020)
4.	Li, Jihong: 1 article (11/2020)
5.	Liu, Yunhan: 1 article (11/2020)
6.	Zhang, Huinan: 1 article (11/2020)
7.	Zhang, Tangrui: 1 article (11/2020)
8.	Zhao, Gang: 1 article (11/2020)
9.	Baaten, Constance C F M J: 1 article (01/2020)
10.	Baerts, Lesley: 1 article (01/2020)

Related Diseases

1.	Reperfusion Injury 02/07/2008 - "Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart." 02/07/2008 - "Here we tested exendin-4 (Exe-4), a peptide agonist at GLP-1 receptors, and GLP-1(9-36) amide, the primary endogenous metabolite of GLP-1 (both in the concentration range 0.03-3.0 nM), for their protective effects against ischemia-reperfusion injury (IRI) in an isolated rat heart preparation. "
2.	Atherosclerosis 01/01/2013 - "However, the effects of the metabolite GLP-1(9-36) on atherosclerosis are unknown. " 01/01/2013 - "Thus, the present study examined the effect of GLP-1(9-36) on chemokine-induced CD4-positive lymphocyte migration as one of the early and critical steps in atherogenesis. "
3.	Stroke (Strokes) 11/15/2020 - "Glucagon-like peptide-1 cleavage product GLP-1(9-36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes."
4.	Thrombosis (Thrombus) 01/01/2020 - "In human blood, GLP-1(7-36), but not DPP-4-cleaved GLP-1(9-36), reduced thrombus volume by 32% and impaired whole blood thrombus formation at both low/venous and high/arterial wall-shear rates. "
5.	Tachycardia (Tachyarrhythmias) 09/01/2010 - "Glucagon-like peptide-1(7-36) had clear regional haemodynamic effects comprising tachycardia, a rise in blood pressure, renal and mesenteric vasoconstriction and hindquarters vasodilatation, whereas GLP-1(9-36) was devoid of any cardiovascular actions. "

Related Drugs and Biologics

1.	Glucagon-Like Peptide 1 (GLP 1)
2.	Amides
3.	Peptides (Polypeptides)
4.	Exenatide (Byetta)
5.	Chemokines
6.	Glucose (Dextrose)
7.	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
8.	Vasodilator Agents (Vasodilators)
9.	Insulin (Novolin)
10.	Glucagon (Glukagon)